- Home
- RCON vs CELU Comparison
RCON vs CELU Comparison
Compare RCON & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCON
- CELU
- Stock Information
- Founded
- RCON 2007
- CELU 2016
- Country
- RCON China
- CELU United States
- Employees
- RCON N/A
- CELU N/A
- Industry
- RCON Oilfield Services/Equipment
- CELU Biotechnology: Pharmaceutical Preparations
- Sector
- RCON Energy
- CELU Health Care
- Exchange
- RCON Nasdaq
- CELU Nasdaq
- Market Cap
- RCON 45.3M
- CELU 42.2M
- IPO Year
- RCON 2009
- CELU N/A
- Fundamental
- Price
- RCON $1.63
- CELU $1.61
- Analyst Decision
- RCON
- CELU
- Analyst Count
- RCON 0
- CELU 0
- Target Price
- RCON N/A
- CELU N/A
- AVG Volume (30 Days)
- RCON 13.4K
- CELU 54.8K
- Earning Date
- RCON 01-01-0001
- CELU 12-06-2024
- Dividend Yield
- RCON N/A
- CELU N/A
- EPS Growth
- RCON N/A
- CELU N/A
- EPS
- RCON N/A
- CELU N/A
- Revenue
- RCON $8,996,572.00
- CELU $48,200,000.00
- Revenue This Year
- RCON N/A
- CELU N/A
- Revenue Next Year
- RCON $12.17
- CELU $233.89
- P/E Ratio
- RCON N/A
- CELU N/A
- Revenue Growth
- RCON N/A
- CELU 225.94
- 52 Week Low
- RCON $1.32
- CELU $1.00
- 52 Week High
- RCON $3.70
- CELU $5.22
- Technical
- Relative Strength Index (RSI)
- RCON 47.36
- CELU 49.49
- Support Level
- RCON $1.45
- CELU $1.47
- Resistance Level
- RCON $1.97
- CELU $1.77
- Average True Range (ATR)
- RCON 0.13
- CELU 0.16
- MACD
- RCON -0.00
- CELU 0.01
- Stochastic Oscillator
- RCON 38.60
- CELU 63.04
About RCON Recon Technology Ltd.
Recon Technology Ltd is an oilfield service company. The company is engaged in providing oilfield automation products, specialized equipment for oil and gas production and transportation, chemicals, and field services to petroleum companies mainly in the People's Republic of China (PRC). It has four reportable operating segments: Automation Product and Software, Equipment and Accessories, Platform outsourcing services, and Oilfield Environmental Protection. The majority of the firm's revenue comes from the Automation Product and Software segment which provides products and services like pumping unit controllers, natural gas flow computer systems, wireless dynamometers and wireless pressure gauges, and an oilfield monitor and data acquisition system among others.
About CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.